Nicotine conjugate vaccine

尼古丁结合疫苗

Report date: 2022/07/04 19:38:02

Base Information

Drug NameNicotine conjugate vaccine
Drug Alias NameNicotine abuse vaccine3'-aminomethyl-Nic r-EPA ConjugateNicVAX3-AMNic-Suc-rEPAAMNic-rEPA
ClassificationVaccines > Development/production technology > Conjugated vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsTobacco Use CessationSmoking ReductionSmoking Cessation +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNetherlands
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesVaxart Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMaastricht University Medical CenterYale UniversityNational Institute On Drug Abuse +[4] 
Active IndicationsN/A
Inactive IndicationsTobacco Use CessationSmoking ReductionSmoking Cessation +[4] 

Other Information

ATC CodeN/A
Related LinksWikipedia